A randomized, double-blind, active controlled, vehicle-controlled, subject initiated study comparing efficacy and safety of ME-609 [aciclovir/hydrocortisone; Lipsovir; Medivir AB] versus acyclovir cream for treatment of recurrent Herpes simplex labialis.

Trial Profile

A randomized, double-blind, active controlled, vehicle-controlled, subject initiated study comparing efficacy and safety of ME-609 [aciclovir/hydrocortisone; Lipsovir; Medivir AB] versus acyclovir cream for treatment of recurrent Herpes simplex labialis.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2015

At a glance

  • Drugs Aciclovir/hydrocortisone (Primary) ; Aciclovir
  • Indications Herpes labialis; Oral ulcer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 17 Jan 2011 Primary endpoint 'Disease-recurrence' has been met
    • 17 Jan 2011 Primary endpoint 'Recurrence-of-infection' has been met
    • 14 Sep 2009 Results were presented at the 49th ACAAC meeting in San Francisco, California, USA.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top